Cholesterolosis of gallbladder medical therapy

Cholesterolosis of gallbladder Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Cholesterolosis of gallbladder from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Cholesterolosis of gallbladder medical therapy On the Web
Most recent articles
cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Cholesterolosis of gallbladder medical therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Cholesterolosis of gallbladder medical therapy
CDC on Cholesterolosis of gallbladder medical therapy
Cholesterolosis of gallbladder medical therapy in the news
Blogs on Cholesterolosis of gallbladder medical therapy
Directions to Hospitals Treating Cholesterolosis of gallbladder
Risk calculators and risk factors for Cholesterolosis of gallbladder medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Medical Therapy

• Pioglitazone has been shown to mobilize cholesterol ester hydrolysis and cholesterol efflux thus lowering lipid content of gallbladder epithelial cells.